Tag Archives: NYSE:SYK

The President & COO of Stryker Corporation (NYSE: SYK) is Selling Shares

Today, the President & COO of Stryker Corporation (SYK – Research Report), Timothy Scannell, sold shares of SYK for $922.4K. Following Timothy Scannell’s last SYK Sell transaction on May 17, 2019, the stock climbed by 14.0%. See today’s analyst top

The VP, Chief Digital Tech Officer of Stryker Corporation (NYSE: SYK) is Selling Shares

Today, the VP, Chief Digital Tech Officer of Stryker Corporation (SYK – Research Report), Bijoy Sagar, sold shares of SYK for $380.8K. Following Bijoy Sagar’s last SYK Sell transaction on December 11, 2018, the stock climbed by 20.4%. In addition

Oppenheimer Sticks to Their Hold Rating for Stryker Corporation (SYK)

In a report released today, Steven Lichtman from Oppenheimer maintained a Hold rating on Stryker Corporation (SYK – Research Report), with a price target of $192. The company’s shares closed yesterday at $186.96. Lichtman wrote: “SYK 1Q19 sales were $3.52B

Analysts Are Bullish on These Healthcare Stocks: Stryker Corporation (SYK), Sarepta Therapeutics (SRPT)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Stryker Corporation (SYK – Research Report) and Sarepta Therapeutics (SRPT – Research Report) with bullish sentiments. Stryker Corporation (SYK) In a report

Oppenheimer Keeps a Hold Rating on Stryker Corporation (SYK)

In a report released today, Steven Lichtman from Oppenheimer maintained a Hold rating on Stryker Corporation (SYK – Research Report), with a price target of $183. The company’s shares closed yesterday at $161.07. Lichtman observed: “SYK reported 4Q18 sales of

The VP & CIO of Stryker Corporation (NYSE: SYK) is Selling Shares

Today, the VP & CIO of Stryker Corporation (SYK – Research Report), Bijoy Sagar, sold shares of SYK for $404.3K. See today’s analyst top recommended stocks >> Based on Stryker Corporation’s latest earnings report for the quarter ending September 30,